Paraprosthetic leak unmasked by combined enoxaparin/warfarin therapy for thrombosed mitral valve.
Barbetseas
John
J
First Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Athens, Greece.
Tsiachris
Dimitris
D
Chrysohoou
Christina
C
Brilli
Stella
S
Bonou
Maria
M
Stefanadis
Christodoulos
C
D000925:Anticoagulants / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D017548:Echocardiography, Transesophageal / Q000379:methods; D017984:Enoxaparin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006349:Heart Valve Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000000981:diagnostic imaging*; D011475:Prosthesis Failure; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control*; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D014859:Warfarin